NFKB1 and Miyoshi myopathy: The NF-κB pathway is mainly activated by binding APRIL or BAFF to BCMA and to protecting MM cells by activating anti-apoptotic proteins like; BCL-XL, BCL-2, MCL-1 [6–8].